Close Menu

mergers & acquisitions

The merger is expected to accelerate the development of integrated tools for cancer diagnosis and characterization.

The $20 million deal expands Caliper's operations into the digital pathology and tissue imaging markets.

GE Healthcare will now undertake a subsequent offering period, which will close next week, to acquire all of the remaining shares that have not yet been tendered.

The acquisition will add human leukocyte antigen antibody detection and other products that are complementary to Gen-Probe's Tepnel business.

In addition to expanding Thermo Fisher's chromatography business, the deal would increase its presence in applied and emerging markets.

According to Caliper President and CEO Kevin Hrusovsky, the acquisition "extends the reach of Caliper's proprietary offerings along the in vitro to in vivo bridge by filling the gap in tissue analysis platforms."

The offer was extended to Dec. 16, so investors can consider disclosures in an amended SEC filing related to a settlement with shareholders.

The purchase of Clinical Data's genetic testing assets gives Transgenomic 11 marketed tests for inherited heart diseases under the Familion brand, PGxPredict tests gauging drug response, tests targeting Fc gamma receptor biomarkers, and a Plavix response test under development.

The acquisition expands Thermo Fisher's lab products and services presence in the Asia Pacific region.

The acquisition provides Source BioSciences with a portfolio of complementary genomics products and services and expands its marketing reach in Europe.

Pages

New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.

A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.

Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.

In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.